Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India
Vishal Goyal(Chandigarh University), Jorge Alvar(Real Academia Española), Temmy Sunyoto, Nathalie Strub‐Wourgaft(Drugs for Neglected Diseases Initiative), Krishna Pandey(Rajendra Memorial Research Institute of Medical Sciences), Fabiana Alves(Drugs for Neglected Diseases Initiative), Sakib Burza(Unknown), Caryn Bern(University of California, San Francisco), Vidya Nand Rabi Das(Rajendra Memorial Research Institute of Medical Sciences), Suman Rijal(Nepal Cancer Hospital and Research Center), Nines Lima(Médecins Sans Frontières), Pradeep Das(Rajendra Memorial Research Institute of Medical Sciences), Ravi Shankar Singh, Allen W. Hightower(Bangkok University), Shambhu Nath Singh
Cited by 15
Related Papers
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
|Clinical Microbiology Reviews|2018|218
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
|PLoS neglected tropical diseases|2017|78
Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis
|BMC Public Health|2017|72